slides · global inventory
Diagnose Problem
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 2,245
Current window 1,531-1,560
Pages 75
Rows per page 30
Slide function
1,531-1,560 of 2,245
07
The slide uses a hierarchical diagram to map the clinical manifestations of the disease.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
11
Includes historical context of diagnostic methods (pre-NBS era).Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
12
The slide uses a table to show symptom overlap (+) and absence (-) between two conditions, accompanied by a visual comparison of patients.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
13
The slide highlights the clinical consequences of missing HCU in newborn screening (NBS).Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
15
Includes a clinical photograph of two patients, likely illustrating physical manifestations or growth issues associated with the condition.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
17
The slide uses a list-based approach to describe the disease burden, paired with a visual column of key clinical manifestations.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
18
The slide uses a simple problem-solution structure, identifying the clinical gap and the resulting need.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
21
The slide uses a pie chart to show patient segmentation by B6 responsiveness and a timeline/number-line to show age of diagnosis, followed by key metrics on complication rates.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
22
Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slidesAeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
05
Aldeyra Therapeutics | Results Presentation Deck | 13 slidesAldeyra Therapeutics | Results Presentation Deck | 13 slides · Aldeyra Therapeutics
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
02
Includes a hub-and-spoke diagram illustrating the effects of pathogenic autoantibodies.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Problem Identification1 hit
07
The slide explains why the company is pivoting or facing financial constraints regarding their UK production plans.Arrival | Results Presentation Deck | 17 slides · Arrival
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
14
The slide uses a before-after-bridge style logic to explain why international operations are underperforming.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations Beat · Problem1 hit
11
Avenue Therapeutics | IPO Presentation Deck | 30 slidesAvenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
12
Avenue Therapeutics | IPO Presentation Deck | 30 slidesAvenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
39
The chart uses a stair-step visualization to show the transition from 'Manufacturable Today' to 'Not Manufacturable Today' based on dose and population size.Berkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations 1 hit
07
Credit Suisse | Investor Event Presentation Deck | 43 slidesCredit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
17
The slide uses a process diagram to illustrate the CAR T cell lifecycle and the microenvironment, followed by a table mapping obstacles to solutions.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Loop · Logic Chain1 hit
54
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
57
The slide highlights the scalability of the manufacturing process by showing the enrichment of iNKT cells.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
65
The diagram illustrates the biological mechanism of iNKT cells interacting with other immune cells (DC, MDSC, Inflammatory Monocyte) to control secondary bacterial pneumonia and inflammation.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
76
The slide uses a numbered list format to categorize distinct barriers: tumor heterogeneity, trafficking, microenvironment, and product quality.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
06
The slide uses a human anatomy diagram to map specific TRK receptor inhibition (TRKB, TRKC, TRKA) to associated clinical side effects.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a 'problem-solution' structure, contrasting current systemic failures with the VBC model.P3 Health Partners | Investor Conference Presentation Deck | 20 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
24
The slide uses a process diagram to explain the Signet payment flow and a list-based comparison to contrast legacy friction with blockchain solutions.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
09
The slide uses a combination of a bar chart for market context and a stacked bar/line chart for internal TCF metrics.Silicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
08
Includes a screenshot of a BMC Neurology paper and a bar chart showing subgroup analysis of OHSA scores.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
25
Uses a visual comparison to explain the biological mechanism of action.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
33
The slide uses a biological mechanism diagram to illustrate the drug's effect on norepinephrine reuptake.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
27
Unilever | Investor Event Presentation Deck | 29 slidesUnilever | Investor Event Presentation Deck | 29 slides · Unilever
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit